ARCHIVES

In Brief: Bruce Chamber Is DeVita’s Choice as Permanent Director Of DCT; Six New RCDAs Funded In FY 1982

This article is from The Cancer Letter archive.

Vol. 08 No. 24 | June 11, 1982

Download PDF Visit The Full Archive

Related Articles

Proof of principle needed before launching “big science” program, advisors say.

March 11, 2005

Mammography’s Best Role Is Screening, Kopans Assert

March 18, 1994

Fischinger Names HHS AIDs Coordinator; DeVita Appoints Maryann Roper Acting Deputy Director

October 30, 1987

NCI STRAP Grants Aim To Move Research Quickly To Clinical Trials

October 1, 2010

Drug Approvals: FDA Approves Vectibix in mCRC With KRAS Companion Diagnostic

May 30, 2014

NIH Consensus Panel Calls for Large Randomized Trials of Hepatitis B Therapies.

October 31, 2008